medullary thyroid carcinoma semaglutide glp-1 cancer Receptor Agonists and Risk, Rodent Data and FDA Warning, • In Advances in the follow-up of

At its highest dose, 36 mg, participants in a phase 3 trial lost an average of 12.4 percent of their starting weight over 72 weeks

Once mixed with liquid, refrigerate and use within a week, or freeze it for longer, avoiding repeated freezing and thawing

Reach out if you experience: Burning, tingling, or skin pain that doesnt improve Skin sensitivity that interferes with sleep, clothing, or daily activities A spreading or worsening Wegovy skin rash Severe itching, swelling, or hives Signs of an allergic reaction, such as trouble breathing or swelling of the face or throat Symptoms that start shortly after increasing your dose of Wegovy A healthcare provider can help determine whether your symptoms are related to the medication, another skin condition, or something else entirely

References Vargas-Soria, M., Garcia-Alloza, M